XPC (xeroderma pigmentosum, complementation group C)

2001-02-01   Anne Stary , Alain Sarasin 

Laboratory of Genetic Instability, Cancer, UPR2169 CNRS, Institut de Recherches sur le Cancer, 7, rue guy Moquet, BP 8, 94801 VILLEJUIF, France

Identity

HGNC
LOCATION
3p25.1
LOCUSID
ALIAS
RAD4,XP3,XPCC,p125
FUSION GENES

DNA/RNA

Description

17703 bp; 16 exons

Transcription

3558 b mRNA

Proteins

Description

939 amino acids

Expression

ubiquitous

Localisation

nuclear

Function

Involved in the early recognition of DNA damage present in chromatine. Two proteins have been identified and implicated in (one of) the first steps of NER, i.e. the recognition of lesions in the DNA: the XPA gene product and the XPC gene product in complex with HR23B. This XPC-HR23B complex has been implicated in DNA damage recognition, especially the cyclobutane pyrimidine dimers induced by UV-light. XPC cells have low Nucleotide Excision Repair (NER) repair capacity, but the residual repair has been shown to occur specifically in transcribed genes. It is very likely that the XPC-HR23B complex is the principal damage recognition complex i.e. essential for the recognition of DNA lesions in the genome. Binding of XPC-HR23B to a DNA lesion causes local unwinding, so that the XPA protein can bind and the whole repair machinery can be loaded onto the damaged site. The XPC-HR23B complex is only required for global genome repair. In case of transcription coupled repair when an RNA polymerase is stalled at a lesion, the DNA is unwound by the transcription complex and XPA can bind independently of XPC-HR23B complex.

Homology

MGI : Xpc (Nb 103557)

Mutations

Germinal

19 mutated sites involved in the XP group C syndrome ( XPC), 95% of these mutations (non sense, frameshift, deletion or splice site mutations) give rise to truncated proteins indicating that the XPC gene is not essential for viability

Implicated in

Entity name
Xeroderma pigmentosum XPC
Disease
predisposition to skin cancer: early skin tumours

Bibliography

Pubmed IDLast YearTitleAuthors

Other Information

Locus ID:

NCBI: 7508
MIM: 613208
HGNC: 12816
Ensembl: ENSG00000154767

Variants:

dbSNP: 7508
ClinVar: 7508
TCGA: ENSG00000154767
COSMIC: XPC

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000154767ENST00000285021Q01831
ENSG00000154767ENST00000285021X5DRB1
ENSG00000154767ENST00000476581Q01831
ENSG00000154767ENST00000511155E7EUB5

Expression (GTEx)

0
10
20
30
40
50
60
70
80
90

Pathways

PathwaySourceExternal ID
Nucleotide excision repairKEGGko03420
Nucleotide excision repairKEGGhsa03420
Metabolism of proteinsREACTOMER-HSA-392499
Post-translational protein modificationREACTOMER-HSA-597592
SUMOylationREACTOMER-HSA-2990846
SUMO E3 ligases SUMOylate target proteinsREACTOMER-HSA-3108232
SUMOylation of DNA damage response and repair proteinsREACTOMER-HSA-3108214
DNA RepairREACTOMER-HSA-73894
Nucleotide Excision RepairREACTOMER-HSA-5696398
Global Genome Nucleotide Excision Repair (GG-NER)REACTOMER-HSA-5696399
DNA Damage Recognition in GG-NERREACTOMER-HSA-5696394
Formation of Incision Complex in GG-NERREACTOMER-HSA-5696395

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA164713176Platinum compoundsChemicalClinicalAnnotationassociatedPD28791697
PA166124386gastrointestinal toxicityDiseaseClinicalAnnotationassociatedPD28791697
PA443512Urinary Bladder NeoplasmsDiseaseClinicalAnnotationassociatedPD19434073, 21047201
PA443622Carcinoma, Non-Small-Cell LungDiseaseClinicalAnnotationassociatedPD28791697
PA444395Hematologic DiseasesDiseaseClinicalAnnotationassociatedPD28791697
PA444773LeukopeniaDiseaseClinicalAnnotationassociatedPD28791697
PA445062NeoplasmsDiseaseClinicalAnnotationassociatedPD19434073, 21047201
PA445601OsteosarcomaDiseaseClinicalAnnotationassociatedPD19434073, 21047201
PA445828Testicular NeoplasmsDiseaseClinicalAnnotationassociatedPD19434073, 21047201
PA449014cisplatinChemicalClinicalAnnotationassociatedPD19434073, 21047201

References

Pubmed IDYearTitleCitations
158826212005UV-induced ubiquitylation of XPC protein mediated by UV-DDB-ubiquitin ligase complex.235
128150742003A novel regulation mechanism of DNA repair by damage-induced and RAD23-dependent stabilization of xeroderma pigmentosum group C protein.85
157461602005Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer.83
129443862003In vivo recruitment of XPC to UV-induced cyclobutane pyrimidine dimers by the DDB2 gene product.81
122423452002p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene.79
159648212005Centrin 2 stimulates nucleotide excision repair by interacting with xeroderma pigmentosum group C protein.76
165278072006Cullin 4A-mediated proteolysis of DDB2 protein at DNA damage sites regulates in vivo lesion recognition by XPC.71
169577812006New functions of XPC in the protection of human skin cells from oxidative damage.71
187014352008Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk.63
191163882009A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility.63

Citation

Anne Stary ; Alain Sarasin

XPC (xeroderma pigmentosum, complementation group C)

Atlas Genet Cytogenet Oncol Haematol. 2001-02-01

Online version: http://atlasgeneticsoncology.org/gene/122/img/logo-atlas-4.svg